1.242SEK-11.29%Mkt Cap: 25.05M SEKP/E: —Last update: 2026-05-21
Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. The company's pipeline products include RMC-035, an intact therape…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap25.05M SEK
Enterprise Value-15.95M SEK
Revenue (TTM)—
Gross Profit0 SEK
Net Income (TTM)-108.85M SEK
Revenue/Share—
Last Price1.242 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0009973357
Valuation
P/E (Trailing)—
P/E (Forward)-0.15
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.62
EPS (TTM)-6.04
EPS (Forward)-8.06
52W Range
0.88101% of range27.00
52W High27.00 SEK
52W Low0.8810 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-267.90%
ROA-201.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-109.35M SEK
CapEx (TTM)—
FCF Margin—
FCF Yield-12.82%
Net Debt-40.99M SEK
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio7.13
Quick Ratio6.55
Book Value/Sh2.015 SEK
Cash/Share2.033 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateDec 15, 2023
Analyst Consensus
Rating—
Target (Mean)1.750 SEK
Target Range1.750 SEK – 1.750 SEK
# Analysts1
Ownership
Shares Out.20.17M
Float15.93M
Insiders28.67%
Institutions37.01%
Technical
SMA 501.290 (-3.7%)
SMA 2007.131 (-82.6%)
Beta—
S&P 52W Chg27.23%
Avg Vol (30d)48.46K
Avg Vol (10d)52.50K
Technical Indicators
RSI (14)50.3
MACD0.0153
MACD Signal-0.0252
MACD Hist.+0.0406
BB Upper1.438 SEK
BB Middle1.143 SEK
BB Lower0.8474 SEK
BB Width51.69%
ATR (14)0.1340 SEK
Vol Ratio (20d)0.28x